FABP4 and breast carcinoma: Patients with breast cancer who had low mRNA expression levels of FABP4 (log-rank P = 0.012), ADIPOQ (log-rank P = 0.01), and PPARG (log-rank P = 0.00013) had worse OS than those with high mRNA levels (Fig. 7).